BTCY Biotricity Inc.

Biotricity, Inc. engages in the provision of biometric data monitoring solutions. The firm offers the Bioflux, a single-unit mobile cardiac telemetry device. It also develops Biolife, which is intended for chronic disease prevention. The company was founded by Waqaas Al-Siddiq and Peter McGoldrick on August 29, 2012 and is headquartered in Redwood City, CA.

As of 09/16/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Medical Devices
Index country:  USA
Country of incorporation:  
IPO date:  02/18/2016
Outstanding shares:  45,479,912
Average volume:  280,171
Market cap:   $155,086,500
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   -8.28
PB ratio:   -37.50
PS ratio:   33.02
Return on equity:   169.72%
Net income %:   -383.01%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy